Novartis

G500-2020-225-Novartis
Stefan Wermuth—Bloomberg/Getty Images

Company Information

As of 2/1/2023
Country
Switzerland
Headquarters
Basel, Switzerland
Industry
Pharmaceuticals
CEO
Vasant Narasimhan
Company Type
Public
Ticker
NVS
Revenues ($M)
$52,263
Profits ($M)
$21,797
Market Value ($M)
$220,198
Employees
104,323
Figures are for the latest twelve months ended Sept. 30, 2022. Market value as of Jan. 20, 2023. Sources: Bloomberg; S&P Global.

World's Most Admired Companies

Sector
Natural resources
Industry
Pharmaceuticals
Current All-Star Rank
-
Previous All-Star Rank
-
Industry Rank
6
Previous Industry Rank
5
Overall Score
7.12
Innovation
7
People Management
9
Use of Corporate Assets
8
Social Responsibility
4
Quality of Management
9
Financial Soundness
7
Long-Term Investment Value
8
Quality of Products/Services
7
Global Competitiveness
4

Key Financials (Last Fiscal Year)

($ Millions)
% change
Revenues ($M)
$52,877
6%
Profits ($M)
$24,021
197.6%
Assets ($M)
$131,795
-
Total Stockholder Equity ($M)
$67,655
-

Profit Ratios

Profit as % of Revenues
45.4%
Profits as % of Assets
18.2%
Profits as % of Stockholder Equity
35.5%
Lists ranking Novartis
RANK248
Global 500 - 2022Aggregate sales hit $37.8 trillion last year—an in...READ MORE
RANK100000
World's Most Admired Companies - 2023The 25th Fortune World’s Most Admired Companies li...READ MORE